Biotage AB (publ) (STO: BIOT)
Sweden
· Delayed Price · Currency is SEK 184.10
+0.10 (0.05%)
Oct 4, 2024, 5:29 PM CET
Biotage AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 2,077 | 1,862 | 1,566 | 1,232 | 1,092 | 1,101 | Upgrade
|
| Revenue Growth (YoY) | 33.66% | 18.90% | 27.11% | 12.82% | -0.85% | 20.91% | Upgrade
|
| Cost of Revenue | 774 | 713 | 618 | 477 | 426 | 415.96 | Upgrade
|
| Gross Profit | 1,303 | 1,149 | 948 | 755 | 666 | 685.41 | Upgrade
|
| Selling, General & Admin | 734 | 636 | 529 | 396 | 375 | 398.75 | Upgrade
|
| Research & Development | 182 | 159 | 109 | 91 | 72 | 78.64 | Upgrade
|
| Other Operating Expenses | 16 | 16 | 17 | 1 | 31 | -1.08 | Upgrade
|
| Operating Expenses | 932 | 811 | 655 | 488 | 478 | 476.32 | Upgrade
|
| Operating Income | 371 | 338 | 293 | 267 | 188 | 209.09 | Upgrade
|
| Interest Expense | -41 | -13 | -5 | -3 | -3 | -2.86 | Upgrade
|
| Interest & Investment Income | 9 | 9 | 2 | - | - | 0.77 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | -1 | -3.38 | Upgrade
|
| Currency Exchange Gain (Loss) | 31 | 26 | 26 | 7 | 14 | 8.45 | Upgrade
|
| Other Non Operating Income (Expenses) | -27 | -27 | 5 | -1 | - | -0.08 | Upgrade
|
| EBT Excluding Unusual Items | 343 | 333 | 321 | 270 | 198 | 211.99 | Upgrade
|
| Merger & Restructuring Charges | -33 | -33 | - | -8 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -1 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -6 | -6 | -1 | -3 | - | - | Upgrade
|
| Other Unusual Items | 9 | 9 | 28 | 10 | 25 | - | Upgrade
|
| Pretax Income | 313 | 303 | 348 | 269 | 222 | 211.99 | Upgrade
|
| Income Tax Expense | 62 | 57 | 80 | 64 | 47 | 25.17 | Upgrade
|
| Net Income | 251 | 246 | 268 | 205 | 175 | 186.82 | Upgrade
|
| Net Income to Common | 251 | 246 | 268 | 205 | 175 | 186.82 | Upgrade
|
| Net Income Growth | 16.20% | -8.21% | 30.73% | 17.14% | -6.33% | 11.45% | Upgrade
|
| Shares Outstanding (Basic) | 80 | 74 | 66 | 65 | 65 | 65 | Upgrade
|
| Shares Outstanding (Diluted) | 80 | 74 | 66 | 65 | 65 | 65 | Upgrade
|
| Shares Change (YoY) | 19.45% | 11.80% | 1.10% | 0.39% | 0.04% | 0.72% | Upgrade
|
| EPS (Basic) | 3.14 | 3.33 | 4.06 | 3.14 | 2.68 | 2.87 | Upgrade
|
| EPS (Diluted) | 3.14 | 3.33 | 4.04 | 3.13 | 2.68 | 2.87 | Upgrade
|
| EPS Growth | -2.20% | -17.57% | 29.07% | 16.62% | -6.36% | 10.66% | Upgrade
|
| Free Cash Flow | 341 | 258 | 306 | 330 | 261 | 196.29 | Upgrade
|
| Free Cash Flow Per Share | 4.26 | 3.49 | 4.62 | 5.04 | 4.00 | 3.01 | Upgrade
|
| Dividend Per Share | 1.600 | 1.600 | 1.600 | 1.550 | 1.500 | - | Upgrade
|
| Dividend Growth | 0% | 0% | 3.23% | 3.33% | - | - | Upgrade
|
| Gross Margin | 62.73% | 61.71% | 60.54% | 61.28% | 60.99% | 62.23% | Upgrade
|
| Operating Margin | 17.86% | 18.15% | 18.71% | 21.67% | 17.22% | 18.98% | Upgrade
|
| Profit Margin | 12.08% | 13.21% | 17.11% | 16.64% | 16.03% | 16.96% | Upgrade
|
| Free Cash Flow Margin | 16.42% | 13.86% | 19.54% | 26.79% | 23.90% | 17.82% | Upgrade
|
| EBITDA | 488 | 432 | 343 | 296 | 217 | 239.09 | Upgrade
|
| EBITDA Margin | 23.50% | 23.20% | 21.90% | 24.03% | 19.87% | 21.71% | Upgrade
|
| D&A For EBITDA | 117 | 94 | 50 | 29 | 29 | 29.99 | Upgrade
|
| EBIT | 371 | 338 | 293 | 267 | 188 | 209.09 | Upgrade
|
| EBIT Margin | 17.86% | 18.15% | 18.71% | 21.67% | 17.22% | 18.98% | Upgrade
|
| Effective Tax Rate | 19.81% | 18.81% | 22.99% | 23.79% | 21.17% | 11.87% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.